These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Allergic contact dermatitis induced by topical hydrocortisone-17-butyrate mimicking papular rosacea. D'Erme AM; Gola M Dermatitis; 2012; 23(2):95-6. PubMed ID: 22653130 [No Abstract] [Full Text] [Related]
9. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations. Shaw DW; Maibach HI Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037 [TBL] [Abstract][Full Text] [Related]
10. Allergic contact dermatitis from dibutyl phthalate, propyl gallate and hydrocortisone in Timodine. Wilkinson SM; Beck MH Contact Dermatitis; 1992 Sep; 27(3):197. PubMed ID: 1451476 [No Abstract] [Full Text] [Related]
11. [THE TOPICAL USE OF VIOFORM-HYDROCORTISONE CREAM IN ALLERGY]. VIZZINI AA Folha Med; 1964 Feb; 48():61-6. PubMed ID: 14271196 [No Abstract] [Full Text] [Related]
12. Contact urticaria syndrome and anaphylactoid reaction from topical clioquinol and bacitracin (Banocin): a case report. Palungwachira P J Med Assoc Thai; 1991 Jan; 74(1):43-6. PubMed ID: 1827491 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a new halcinonide-antifungal combination. Barba-Rubio J Curr Ther Res Clin Exp; 1976 Nov; 20(5):655-60. PubMed ID: 136333 [No Abstract] [Full Text] [Related]
14. Allergic contact dermatitis induced by topical hydrocortisone butyrate propionate mimicking acute generalized exanthematous pustulosis. TOHGI N; ETO H; MAEJIMA H; SAITO N; NAKAMURA M; KATSUOKA K Eur J Dermatol; 2009; 19(5):518-9. PubMed ID: 19527994 [No Abstract] [Full Text] [Related]
15. Short induction phase of contact allergy to tixocortol pivalate in a nasal spray. Bircher AJ Contact Dermatitis; 1990 Apr; 22(4):237-8. PubMed ID: 2140756 [No Abstract] [Full Text] [Related]
18. Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis. Goldust M; Rezaee E; Masoudnia S; Raghifar R Ann Parasitol; 2013; 59(3):119-23. PubMed ID: 24881281 [TBL] [Abstract][Full Text] [Related]
19. Systemic eczematous contact-type dermatitis induced by iodochlorhydroxyquin and chloroquine phosphate. Skog E Contact Dermatitis; 1975 Jun; 1(3):187. PubMed ID: 138510 [No Abstract] [Full Text] [Related]
20. A new formulation of 0.1% hydrocortisone cream with vasoconstrictor activity and clinical effectiveness. Whitefield M; McKenzie AW Br J Dermatol; 1975 May; 92(5):585-8. PubMed ID: 126075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]